Past Cafés

Join ASGCT to Access the Archive

ASGCT Members have access to all of our Professional Development Cafes. Become a member today and watch all the cafes on demand!

2022 Archive

Jan.: "How To" with CAR T-Cell Therapy

During this café, ASGCT Member Stephen Gottschalk, MD (St. Jude's Children's Research Hospital) led a structured discussion about CAR T-cell therapy.

March: How to Set Up Pre-Clinical Studies

This café is the first of a two-part series hosted by Andrew Steinsapir, a gene therapy program lead at Deerfield Discovery and Development.

April: Translating Pre-Clinical to Clinical Studies

Following a successful part one, April’s Professional Development Café brought attendees to the second part of this two-part series once again hosted by Andrew Steinsapir.

June: Tumor-Infiltrating Lymphocytes & Tumor-Specific Antigens

ASGCT Associate Member Vincenzo Cerullo, PhD, discussed tumor-infiltrating lymphocytes (TILs) and tumor-specific antigens (TSAs).

July: Introduction to GMP Regulations

Attendees heard from speakers Gautam Ranade, Jasna Curak, and Stephan Croft during this session on Good Manufacturing Practices (GMPs).

Aug.: The ABCs of Starting Your Own Company

Are you interested in starting your own gene or cell therapy company? Learn more about the process from Matthew Hirsch, PhD, R. Jude Samulski, PhD, and Ben Yerxa, PhD.

Sept.: Science Literacy: Educating Others by Taking Back the Story

Grant Holley, PhD, talked to attendees about how to better exxplain what they do in the lab and why they do it.

Oct.: Team Management: Surrounding Yourself with the Right People

We heard from Curtis Henry, PhD, who shared his insights on how to build and maintain an effective team. 

Nov.: Scientific Horizons and Ethical Limits of Gene and Cell Therapy

Speakers Ben Hurlbut, PhD, and Krishanu Saha, PhD, explored the ethical dimensions of research undertaken by the ASGCT community. 

2023

26th Annual Meeting

May 16-20 | Los Angeles, CA

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.